Rtw Investments, LP
85 holdingsFiling period: 2026-06-30Current AUM: $11.28Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | MDGL | Madrigal Pharmaceuticals Inc | 1.99M | $1.07B | $860.7M | 7.63% | -- | 2026-06-30 |
| 2 | ARGX | Argenx SE | 709.4K | $658.2M | $637.0M | 5.64% | -- | 2026-06-30 |
| 3 | PTCT | Ptc Therapeutics Inc | 7.75M | $631.9M | $499.3M | 4.42% | -- | 2026-06-30 |
| 4 | PTGX | Protagonist Therapeutics Inc | 5.06M | $620.4M | $730.5M | 6.47% | +2.1K | 2026-06-30 |
| 5 | CGON | CG Oncology Inc | 8.51M | $605.0M | $540.4M | 4.79% | +1.53M | 2026-06-30 |
| 6 | INSM | Insmed Inc | 4.84M | $516.3M | $540.4M | 4.79% | -- | 2026-06-30 |
| 7 | TNGX | Tango Therapeutics Inc | 13.90M | $434.5M | $313.2M | 2.78% | +600.0K | 2026-06-30 |
| 8 | SYRE | Spyre Therapeutics Inc | 4.25M | $377.5M | $420.8M | 3.73% | +80.0K | 2026-06-30 |
| 9 | CELC | Celcuity Inc | 3.30M | $345.8M | $229.0M | 2.03% | +265.3K | 2026-06-30 |
| 10 | ERAS | Erasca Inc | 17.95M | $328.8M | $268.8M | 2.38% | +1.79M | 2026-06-30 |
| 11 | RDNT | Radnet Inc | 4.85M | $298.9M | $357.0M | 3.16% | +562.0K | 2026-06-30 |
| 12 | ORKA | Oruka Therapeutics Inc | 3.14M | $298.7M | $303.4M | 2.69% | +1.08M | 2026-06-30 |
| 13 | NTRA | Natera Inc | 1.00M | $271.4M | $436.0M | 3.86% | -250,000 | 2026-06-30 |
| 14 | RARE | Ultragenyx Pharmaceutical in | 7.80M | $260.3M | $130.8M | 1.16% | +4.15M | 2026-06-30 |
| 15 | IRTC | Irhythm Holdings Inc | 2.18M | $259.6M | $278.9M | 2.47% | +514.1K | 2026-06-30 |
| 16 | CYTK | Cytokinetics Inc | 2.86M | $243.8M | $181.2M | 1.61% | +140.8K | 2026-06-30 |
| 17 | KLRA | Kailera Therapeutics Inc | 10.78M | $237.4M | $144.5M | 1.28% | -- | 2026-06-30 |
| 18 | — | Establishment Labs Hldgs Inc | 2.66M | $227.9M | $227.9M | 2.02% | -- | 2026-06-30 |
| 19 | GH | Guardant Health Inc | 1.48M | $222.2M | $274.4M | 2.43% | -- | 2026-06-30 |
| 20 | NBIX | Neurocrine Biosciences Inc | 1.27M | $213.7M | $185.6M | 1.64% | +205.9K | 2026-06-30 |
| 21 | TARS | Tarsus Pharmaceuticals Inc | 3.36M | $211.3M | $249.1M | 2.21% | +11.0K | 2026-06-30 |
| 22 | STOK | Stoke Therapeutics Inc | 5.62M | $184.0M | $148.2M | 1.31% | -- | 2026-06-30 |
| 23 | — | Uniqure NV | 3.94M | $181.5M | $181.5M | 1.61% | +1.36M | 2026-06-30 |
| 24 | ACAD | Acadia Pharmaceuticals Inc | 7.14M | $180.8M | $148.3M | 1.31% | -- | 2026-06-30 |
| 25 | RGEN | Repligen Corp | 1.24M | $169.3M | $234.0M | 2.07% | +34.6K | 2026-06-30 |
← Scroll →
Page 1 of 4